Related Experiment Video
Updated: Sep 15, 2025

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats
Published on: December 13, 2019
Assessing LV Contractility Identifies Populations With Preserved Ejection Fraction at Risk of Adverse Heart Failure
Sam Straw1, Oliver I Brown1, Charlotte A Cole2
1Leeds Institute of Cardiovascular and Metabolic Medicine (S.S., O.I.B., M.C.-R., M.F.P., M.D., T.A.S., E.L., K.K.W., M.T.K., R.M.C., J.G.), University of Leeds, United Kingdom.
The cardiac contractility index (CCI) effectively predicts heart failure (HF) risk, even in patients with normal left ventricular ejection fraction (LVEF). This simple, noninvasive measure offers valuable prognostic insights for HF populations.
Area of Science:
- Cardiology
- Clinical Research
- Biomedical Engineering
Background:
- Left ventricular ejection fraction (LVEF) is a standard heart failure (HF) assessment tool but is limited by load dependence.
- There is a need for additional tools to risk-stratify patients with normal LVEF.
- The cardiac contractility index (CCI), a ratio of systolic blood pressure to left ventricular end-systolic volume, was investigated.
Purpose of the Study:
- To assess the prognostic value of the cardiac contractility index (CCI).
- To evaluate CCI's association with subclinical myocardial dysfunction and incident HF.
- To determine if CCI can risk-stratify patients with normal LVEF.
Main Methods:
- Prospective observational cohort study of newly diagnosed HF patients.
- Analysis of UK Biobank data for associations between CCI, myocardial dysfunction, and incident HF.
- Stratification into HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF) groups.
Main Results:
- In HF patients, declining CCI correlated with increased mortality (P<0.001).
- In HFpEF, below-median CCI indicated higher mortality risk (17.3/100 patient-years) compared to above-median CCI (8.8/100 patient-years; P<0.001).
- In individuals without HF and normal LVEF, below-median CCI was linked to a 33% increased risk of incident HF (aHR, 1.33; P=0.043).
Conclusions:
- CCI is a simple, noninvasive, and relatively afterload-independent method for stratifying HF risk, particularly in normal LVEF populations.
- CCI's simplicity allows for application to existing clinical trial data and use in future randomized controlled trials.
More Related Videos
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Cardiomyopathy III: Hypertrophic Cardiomyopathy

